BIO KEY INTERNATIONAL Business Summary

BIO-key International Inc. (BKYI) is a specialized provider of Identity and Access Management (IAM) and biometric authentication solutions, generating revenue through a diversified mix of recurring software-as-a-service (SaaS) subscriptions, perpetual software licenses, and the sale of proprietary hardware. The company’s business is structured into two primary segments: enterprise software, featuring the PortalGuard IAM platform and the WEB-key biometric engine, and biometric hardware, which includes a line of FBI-certified fingerprint scanners such as EcoID III, SideSwipe, and SidePass. BIO-key differentiates itself in the cybersecurity market through its "Identity-Bound Biometrics" (IBB) technology, which authenticates the individual user rather than a specific device or token, primarily targeting high-compliance sectors such as global defense, financial services, and government. It competes directly with major identity providers like Okta, Microsoft (Entra ID), and Ping Identity, as well as biometric hardware manufacturers like NEXT Biometrics, positioning itself as a hardware-agnostic alternative that offers centralized biometric identity verification. Founded in 1993, BIO-key is currently led by Chairman and CEO Michael W. DePasquale, who has served as the firm's chief executive since 2003 and brings over 30 years of technology leadership experience from previous roles at Prism eSolutions and McGraw-Hill. The executive team includes Chief Technology Officer Mira LaCous, a veteran in biometric software architecture, and Chief Financial Officer Cecilia Welch, who manages the company’s financial strategy and its ongoing transition toward a SaaS-driven revenue model. A pivotal figure in the company’s capitalization and international expansion is Vice Chairman Wong Kwok Fong (Kelvin), a major investor and electronics manufacturing expert who was instrumental in the company’s 2015 NASDAQ listing. The company’s governance is overseen by a board that includes Robert J. Michel and Cameron E. Williams, with institutional backing from notable investors such as The Lind Partners, Geode Capital Management, and Vanguard Group.